|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00410267 |
|
Date of registration:
|
11/12/2006 |
|
Primary sponsor: |
|
|
Public title:
|
Trial Comparing Ketorolac Tromethamine 0.4% and Prednisolone Acetate 1% in Reducing Post-Selective Laser Trabeculoplasty Anterior Chamber Flare and Cells
|
|
Scientific title:
|
A Randomized Prospective Double - Masked Controlled Trial Comparing Ketorolac Tromethamine 0.4% and Prednisolone Acetate 1% in Reducing Post-Selective Laser Trabeculoplasty Anterior Chamber Flare and Cells |
|
Date of first enrolment:
|
February 2006 |
|
Target sample size:
|
1 |
|
Recruitment status: |
Terminated |
|
URL:
|
http://clinicaltrials.gov/show/NCT00410267 |
|
Study type:
|
Observational |
|
Study design:
|
N/A
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Joel S Schuman, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Pittsburgh |
|
|
Name:
|
Robert J Noecker, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Pittsburgh |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients diagnosed with open angle glaucoma at the University of Pittsburgh Medical
Center (UPMC) Glaucoma Clinic.
- Able to provide written informed consent to participate.
- Must be between the ages of 18 - 95.
- Patients in which further IOP lowering by SLT is necessary in the opinion of the
treating physician.
Exclusion Criteria:
- Patients with eye surgery in the prior six months.
- Patients with prior or current use of topical or systemic corticosteroids or NSAIDs.
- Patients with pre-existing anterior chamber inflammation.
- Patients with known sensitivity to any of the study medications.
- Due to the age range and the disease entity, special patient populations such as
children or pregnant women will not be enrolled in this study.
Age minimum:
18 Years
Age maximum:
95 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Glaucoma, Open-Angle
|
|
Inflammation
|
|
Postoperative Complications
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|